Innovator’s Pitch Challenge

Diagnostics & Therapeutics

Thursday, March 16
4:00 – 5:00pm ET

Amplified Sciences is a clinical stage life science in-vitro diagnostics company with an ultra-sensitive molecular-sensing platform technology with composition of matter IP exclusively licensed from Purdue University focused on accurately detecting debilitating diseases sooner. Their lead assay for early detection of pancreatic cancer is supported with clinical published data and provides increased accuracy and earlier detection helping gastroenterologists stratify patients at risk for pancreatic cancer. Open $3M Series Seed Preferred, led by OCA Ventures and Elevate Ventures will fund opening of clinical lab, CLIA regulatory milestone, and support commercial launch in 2023 as well as scale additional assays on their ultrasensitive chemistry reagent platform.

Contact Us:

Diana Caldwell